Ken Griffin Bruker Corp Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$60.3 - $70.67 $542,700 - $636,030	9,000 Added 187.5%	13,800 $953,000
Q2 2024 Aug 14, 2024	SELL	$63.57 - $92.93 $1.48 Million - $2.17 Million	-23,300 Reduced 82.92%	4,800 $306,000
Q1 2024 May 15, 2024	SELL	$69.21 - $94.27 $110,735 - $150,832	-1,600 Reduced 5.39%	28,100 $2.64 Million
Q4 2023 Feb 14, 2024	BUY	$54.91 - $74.64 $225,131 - $306,024	4,100 Added 16.02%	29,700 $2.18 Million
Q3 2023 Nov 14, 2023	SELL	$61.34 - $75.77 $294,432 - $363,696	-4,800 Reduced 15.79%	25,600 $1.59 Million
Q2 2023 Aug 14, 2023	BUY	$69.1 - $84.02 $1.69 Million - $2.06 Million	24,500 Added 415.25%	30,400 $2.25 Million
Q1 2023 May 15, 2023	SELL	$65.49 - $78.84 $1.98 Million - $2.39 Million	-30,300 Reduced 83.7%	5,900 $465,000
Q4 2022 Feb 14, 2023	SELL	$54.36 - $69.91 $1.13 Million - $1.45 Million	-20,800 Reduced 36.49%	36,200 $2.47 Million
Q3 2022 Nov 14, 2022	BUY	$48.91 - $69.04 $1.69 Million - $2.39 Million	34,600 Added 154.46%	57,000 $3.02 Million

385

101M

33K

39.5K

Ticker BRKR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 148,138,000
Market Cap $8.44B
Description
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.